Top > News Releases
Y's Therapeutics Co., Ltd. appointed Susumu Yamada as board member&CBO, and Akira Murakami & Yoshihiro Ito as Auditors on June 8, 2009.
Susumu Yamada (Board member & CBO)
1967 BA in Economic, The University of Tokyo
1967 The Long-Term Credit Bank of Japan, Ltd.
1974 MBA, University of Chicago
1984 Board member, S.G.Warburg & Co., Ltd.
1989 Board member, Hoxan corporation, Ltd.
1993 Managing director, Board member, Air Water Inc.(fomerly Daido Hoxan Inc.)
1997 Senior Managing director, Board member, Air Water Inc.(fomerly Daido Hoxan
Inc.)
2001 President, Kinetics Japan K.K.
2004 Auditor, Y's Therapeutics Co., Ltd.
2006 Resigned Auditor, Y's Therapeutics Co., Ltd.
2008 Auditor, Y's Therapeutics Co., Ltd.
2009 Resigned Auditor, Y's Therapeutics Co., Ltd.
2009 Board member & CBO, Y's Therapeutics Co., Ltd. (current position)
About Y's Therapeutics
Y's Therapeutics (http://www.ysthera.com) is a privately held biopharmaceutical company engaged
in the R&D of novel therapeutics for the treatment of inflammation-mediated diseases, cancer, and other unmet medical needs.
Y's focuses on the development of preclinical and early-stage clinical projects pursued through research collaborations and
in-licensing opportunities from academic institutions and biotech companies. Y's is seeking collaborative relationships,
including out-licensing of product rights and creation of joint ventures, for late-stage development,
manufacturing and commercialization of its portfolio products. The company currently has several projects
in its clinical and preclinical pipeline. Y's has operations in two locations, Y's Therapeutics Co., Ltd.,
of Tokyo, Japan, and Y's Therapeutics, Inc., of San Bruno, CA.
◈CONTACT◈
Kyoko Harigae
Administrations Department
Y's Therapeutics Co., Ltd.
+011-81-3-5784-2762
E-Mail：admin@ysthera.com
 |
 |
Top | Site Map | Access Map | Privacy Policy | Terms of Use |
